Aardvark Therapeutics, Inc.
AARD
$5.39
$0.020.37%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -17.60M | -16.32M | -14.37M | -9.31M | -8.78M |
| Total Depreciation and Amortization | 10.00K | 10.00K | 11.00K | 5.00K | 8.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.45M | 1.18M | 127.00K | 274.00K | 229.00K |
| Change in Net Operating Assets | -673.00K | -999.00K | 4.39M | -2.36M | 815.00K |
| Cash from Operations | -16.81M | -16.13M | -9.84M | -11.39M | -7.73M |
| Capital Expenditure | 0.00 | -4.00K | -91.00K | -- | -6.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 24.30M | 29.25M | 9.50M | -112.62M | -11.89M |
| Cash from Investing | 24.30M | 29.25M | 9.41M | -112.62M | -11.90M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 274.00K | 171.00K | 6.00K | 91.19M | 163.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | 0.00 |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | 0.00 | -77.00K | -2.31M | -1.18M |
| Cash from Financing | 274.00K | 171.00K | -71.00K | 88.88M | -1.01M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 7.77M | 13.29M | -506.00K | -35.14M | -20.64M |